Unique ID issued by UMIN | UMIN000017169 |
---|---|
Receipt number | R000019917 |
Scientific Title | Evaluation of adjuvant pancreatectomy for initially unresectable pancreatic cancer with preoperatively undetectable distant metastasis after chemotherapy |
Date of disclosure of the study information | 2015/04/20 |
Last modified on | 2015/11/18 18:23:32 |
Evaluation of adjuvant pancreatectomy for initially unresectable pancreatic cancer with preoperatively undetectable distant metastasis after chemotherapy
Evaluation of adjuvant pancreatectomy for initially unresectable pancreatic cancer with preoperatively undetectable distant metastasis after chemotherapy
Evaluation of adjuvant pancreatectomy for initially unresectable pancreatic cancer with preoperatively undetectable distant metastasis after chemotherapy
Evaluation of adjuvant pancreatectomy for initially unresectable pancreatic cancer with preoperatively undetectable distant metastasis after chemotherapy
Japan |
pancretatic cancer
Hepato-biliary-pancreatic surgery |
Malignancy
NO
Evaluation of adjuvant pancreatectomy for initially unresectable pancreatic cancer with distant micro metastasis after chemotherapy
Efficacy
survival rate at 2-year.
overall survival
recurrent free survival at 1-year
R0 resection rate
pattern of recurrence
tumor marker
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Maneuver |
Pancreatectomy for the patients with disease control with chemotherapy for more than 3 months
20 | years-old | <= |
Not applicable |
Male and Female
(1) histolycally proven invasive pancreatic ductal adenocarcinoma
(2) the number of intraabdominal distant metastasis is 5 or less, and all of them were removed for histological diagnosis at laparotomy
(3)no distant metastasis with preoperative imaging (CT, MRI, FDG-PET-CT)
(4) R01 resection is possible for primary cancer
(5) with tolerable health to operation
(6) no prior therapy for pancreas cancer except for metastatectomy at 1st laparotomy
(7) not enrolled in other study with primary endpoint of resection or survival
(8) no other active cancer
(9) expect survival time is 6-month and more
(10) with consent in a writing form
(11) 20 years old or older with judgement
(1) not diagnosed as invasive pancreatic ductal adenocarcinoma
(2) the number of distant metastasis is 6 or more
(3) with detectable distant metastasis by preoperative image
(4) R2 resection is expected
(5) without tlerable health to operation
(6) recurrent pancreatic cancer
(7) enrolled in other study with primary endpoint of resection or survival
(8) with another active cancer
(9) with uncontrollable infection
(10) in pregnancy
(11) expected survival time is less than 6 months
(12) chemotherapy is difficult
(13) younger than 20 years old
(14) without judgement
75
1st name | |
Middle name | |
Last name | Hiroki Hayashi |
Tohoku University
Surgery
Sendai
022-717-7205
hiroki@srurg1.med.tohoku.ac.jp
1st name | |
Middle name | |
Last name | Hiroki Hayashi |
Tohoku University
Surgery
Sendai
922-717-7205
hiroki@surg1.med.tohoku.ac.jp
Department of surgery, Tohoku university school of medicine
None
Self funding
NO
2015 | Year | 04 | Month | 20 | Day |
Unpublished
Enrolling by invitation
2015 | Year | 03 | Month | 10 | Day |
2015 | Year | 04 | Month | 20 | Day |
2020 | Year | 03 | Month | 01 | Day |
2015 | Year | 04 | Month | 18 | Day |
2015 | Year | 11 | Month | 18 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019917
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |